Long Path Partners LP

STAMFORD, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$220.8M2026 Q3
Positions8
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Long Path Partners LP reported 8 positions worth $220.8M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: MLAB (28.3%). Biggest move: reduce CPAY ($15.4M).

8 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 MLABMesa Laboratories$62.4M28.26%480,169——+7.0%
▸ 2 NCNOnCino$61.7M27.92%3,400,880——+25.5%
▸ 3 ALKTAlkami Technology$25.6M11.60%1,870,732——+2.1%
▸ 4 TYLTyler Technologies$22.2M10.06%69,735——+33.1%
▸ 5 CPAYCorpay$18.6M8.43%47,900——+18.9%
▸ 6 TDGTransDigm$12.3M5.55%11,324——+12.4%
▸ 7 PCORProcore Technologies$9.3M4.21%179,665——+50.1%
▸ 8 VEEVVeeva Systems$8.8M3.97%30,679——+5.6%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Long Path Partners LP hold as of Q3 2026?

Long Path Partners LP reported 8 positions worth $220.8M in its Q3 2026 13F filing. Largest positions: MLAB (28.3%), NCNO (27.9%), ALKT (11.6%), TYL (10.1%) and CPAY (8.4%).

What did Long Path Partners LP buy in Q3 2026?

Added to: TDG, TYL, MLAB and PCOR.

What did Long Path Partners LP sell in Q3 2026?

Reduced: CPAY, VEEV, ALKT and NCNO. Sold out entirely: SPSC and IIIV.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.